PCM
BIVI icon

Prelude Capital Management’s BioVie BIVI Stock Holding History

Prelude Capital Management’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.2K Sell
32,583
-59,480
-65% -$93.4K ﹤0.01% 1158
2026
Q1 		$129K Hold
92,063
– – 0.01% 1003
2025
Q4 		$107K Sell
92,063
-52,699
-36% -$84.8K 0.01% 1176
2025
Q3 		$275K Buy
+144,762
New +$586K 0.02% 775

Other funds holding BIVI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prelude Capital Management's BIVI Position: Q2 2026 in Review

Prelude Capital Management reduced its BioVie (BIVI) stake by 65% in Q2 2026, selling an estimated $93.4K and leaving 32,583 shares worth $63.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Prelude Capital Management first reported a position in BIVI in Q3 2025 and has held it in 4 quarters since. The position peaked at $275K in Q3 2025. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • Prelude Capital Management held 32,583 shares of BioVie worth $63.2K as of Q2 2026.
  • Prelude Capital Management sold 59,480 BioVie shares in Q2 2026, an estimated $93.4K.
  • BioVie made up ﹤0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1158 holding.
  • Prelude Capital Management first reported a position in BioVie in Q3 2025 and has held it in 4 quarters since.
  • Prelude Capital Management's BioVie position peaked at $275K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.